⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Rena Therapeutics Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Rena Therapeutics Inc.
↗Tokyo, Japan
Rena Therapeutics is a Japanese biotechnology venture founded in 2015, originating from Tokyo Medical and Dental University. The company specializes in the development of Heteroduplex Oligonucleotide (HDO) technology, a novel nucleic acid drug discovery platform designed to overcome delivery, stability, and toxicity challenges associated with conventional oligonucleotide therapeutics.
As a subsidiary of Nippon Shokubai, Rena Therapeutics focuses on licensing its HDO platform, conducting collaborative R&D with pharmaceutical partners, and providing HDO manufacturing services. The company's technology enables systemic administration and targeted gene control in organs beyond the liver, positioning it as a key player in the next-generation nucleic acid medicine landscape.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Nucleic Acid Therapeutics / Drug Delivery Systems
SIZE & FINANCIALS
Employees:1-50
Founded:2015
Ownership:subsidiary
Status:operating
FUNDING
Investors:Nippon Shokubai
PIPELINE
Stage:Discovery
Lead Drug Stage:Discovery
Modalities:Nucleic acid therapeutics, Oligonucleotides
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Nippon Shokubai
Acquired By:Nippon Shokubai (2019-11-01)
Key Partnerships:Takeda Pharmaceutical (Licensing/Collaboration), Ionis Pharmaceuticals (Licensing), Nippon Shokubai (Parent/Manufacturing)
COMPETITION
Position:Emerging
Competitors:Ionis Pharmaceuticals, Alnylam Pharmaceuticals
LEADERSHIP
Key Executives:
Shuichi Toriya - Representative Director & CEO
Scientific Founders:Prof. Takanori Yokota, Prof. Satoshi Obika
LINKS
Website:renatherapeutics.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Rena Therapeutics Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.